Read + Share
Amedeo Smart
Independent Medical Education
Zeiser R, Polverelli N, Ram R, Hashmi SK, et al. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease. N Engl J Med 2021;385:228-238.PMID: 34260836
Email
LinkedIn
Facebook
Twitter
Privacy Policy